DTC Ads, Third-Party Audits Are CDRH Compliance Office Priorities In 2006
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is focused on ensuring that the most important risk information is disclosed in direct-to-consumer advertisements, according to CDRH Office of Compliance Director Tim Ulatowski
You may also be interested in...
Device Firms Need More Help Making Direct-To-Consumer “Brief Statements”
Device manufacturers should be given the opportunity to have FDA review their direct-to-consumer ads for restricted devices before they go public, according to AdvaMed
Accredited-Person Inspection Guidance Heeds NEMA’s Comments
FDA took another step toward implementing its fledgling third-party quality systems inspection program with the release of a final guidance Sept. 15
Third-Party Inspection Training Stymied By Lack Of Industry Hosts
Implementation of FDA's accredited persons (AP) inspection program may require the agency to conduct compliance audits in addition to those scheduled in the Office of Regulatory Affairs workplan